Fig. 6
From: Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy
Recovered T-cell frequencies and function at baseline in AML patients. a Frequencies of total CD3+, CD4+ T-helper, and CD8+ T-cytotoxic cells in HD and AML baseline. b Frequencies of total CD4+ FOXP3+ T-regs, naïve T-regs and of memory T-regs in HD and AML baseline. Mean frequencies indicated by blue lines. c Influenza-specific cytokine secretion on day 30 versus baseline in 5 evaluable AML patients, including two responders (red) and three non-responders (black). AML patients indicated in figure key